Stephen Ruiz

6PUBLICATIONS
56CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer cell biologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 24, 2026
Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer.

|Mar 23, 2026
Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer.

Clemens Hinterleitner, Valentin J A Barthet, Hailey V Goldberg

|Dec 05, 2025
Tumor microenvironment-targeted PROTAC nanoparticle self-assembly broadly predicted by structural descriptors.

Kristen C Vogt, Magdalini Panagiotakopoulou, Mandana T Manzari Honu

|Jul 02, 2025
Phospholipase PAFAH2 Mediates Ferroptosis Surveillance and Lipid Remodeling to Promote Resistance in KEAP1 Mutant Cancers.

Stephen B Ruiz, Daniel E Tylawsky, Janki Shah

|Jun 23, 2023
Micro-engineering and nano-engineering approaches to investigate tumour ecosystems.

Mijin Kim, Magdalini Panagiotakopoulou, Chen Chen

|Sep 02, 2022
Megakaryopoiesis impairment through acute innate immune signaling activation by azacitidine.

Ujunwa Cynthia Okoye-Okafor, Komal K Javarappa, Dimitrios Tsallos

Pageof 1

Frequent Collaborators

5 joint publications

Daniel A Heller

3 joint publications

Ana Marie Perea

3 joint publications

Kristen C Vogt

2 joint publications

Magdalini Panagiotakopoulou